Transcriptomics

Dataset Information

0

Pharmacological inhibition of FKBP51 mitigates early life adversity-induced social deficits


ABSTRACT: Early life adversity (ELA) is a major risk factor for psychiatric disorders, but targeted preventative strategies are lacking due to poor mechanistic insight. The FKBP51 protein, a co-chaperone of the glucocorticoid receptor, is a key mediator of stress vulnerability. We tested if pharmacological inhibition of FKBP51 with the selective inhibitor SAFit2 prevents the long-term consequences of ELA. Mice exposed to ELA exhibited persistent deficits in social behavior, manifesting as social subordination in adolescence and adulthood. Early-life SAFit2 treatment fully rescued these ELA-induced behavioral impairments. Transcriptional profiling across six stress-relevant brain regions revealed that SAFit2 normalized ELA-driven gene expression changes, particularly in the medial prefrontal cortex and nucleus accumbens. Functional analysis showed the rescue converged on immunoregulatory and neuroactive ligand-receptor signaling pathways. Our findings establish FKBP51 as a critical pharmacological target for reversing the lasting impact of early life adversity on brain function, offering a path toward preventative treatment for ELA-related psychopathology.

ORGANISM(S): Mus musculus

PROVIDER: GSE318028 | GEO | 2026/07/15

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-09-22 | GSE151827 | GEO
2021-01-31 | GSE164056 | GEO
2023-04-16 | GSE228702 | GEO
2022-04-05 | GSE199982 | GEO
2025-10-14 | GSE293520 | GEO
2020-12-15 | GSE161498 | GEO
2022-05-06 | GSE174085 | GEO
2024-02-26 | GSE256468 | GEO
2020-05-29 | GSE151342 | GEO
2025-02-18 | GSE288870 | GEO